Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020860419> ?p ?o ?g. }
- W2020860419 endingPage "261" @default.
- W2020860419 startingPage "253" @default.
- W2020860419 abstract "To assess at serial intervals the production of interleukin-12 (IL-12) by monocytes/macrophages from the peripheral blood of injured patients and control subjects, and using a mouse model to confirm human findings and explore the effectiveness of low-dose IL-12 therapy in restoring resistance to infection after injury.Serious injury is associated with loss of function of the T helper 1 lymphocyte phenotype, but little is known about IL-12 production in injured patients. The authors previously reported that early, moderate-dose IL-12 therapy in a mouse model of burn injury restored resistance to a later infectious challenge (cecal ligation and puncture, CLP). However, the efficacy of clinically relevant low-dose IL-12 therapy carried out to or beyond the time of septic challenge remains to be tested.Peripheral blood mononuclear cells (PBMCs) and adherent cells were obtained from 27 patients with major burns or traumatic injury and 18 healthy persons and were studied at serial intervals for IL-12 production stimulated by bacterial lipopolysacharide (LPS). PBMCs from 18 of the same patients were studied for IL-10 production as well. IL-12 production by adherent cells from the spleens of burn or sham burn mice was studied at serial intervals after injury to confirm the human findings. Low-dose IL-12 or vehicle was given every other day to groups of burn and sham burn mice, which were then challenged with CLP on day 10, and survival was determined. Finally, spleens were harvested from burn or sham burn animals receiving low-dose IL-12 or vehicle after CLP. After splenic cellularity was determined by hemocytometer, splenocytes were cultured and production of tumor necrosis factor-alpha, interferon-gamma, and IL-10 were assessed by immunoassay.Adherent cells from patients' PBMCs produced significantly less IL-12 than normal PBMCs after injury, reaching a nadir 8 to 14 days after injury. Stimulation of whole PBMCs by LPS indicated that at 8 to 14 days after injury, IL-12 production by PBMCs was significantly lower and IL-10 production was significantly higher than that of PBMCs from healthy persons. Low-dose IL-12 therapy significantly increased survival after CLP. Splenocytes from burn mice treated with IL-12 had significantly increased production of TNF-alpha and IF-beta, both before and after CLP, when compared with vehicle-treated burn animals. IL-10 production by bum splenocytes remained high after IL-12 treatment. Splenic cellularity increased after IL-12 treatment in burn mice.The capacity to produce IL-12 by adherent cells of the monocyte/macrophage lineage is significantly reduced after serious injury in humans and in a mouse burn model. In humans, there is a reciprocal relation between diminished IL-12 production and increased IL-10 production at approximately 1 week after injury. Low-dose IL-12 therapy in the mouse burn model markedly increased survival after a septic challenge, even when treatment was carried beyond the onset of sepsis. Low-dose IL-12 treatment in the mouse increased production of proinflammatory mediators important in host defense and at the same time maintained or increased production of IL-10, an important antiinflammatory cytokine." @default.
- W2020860419 created "2016-06-24" @default.
- W2020860419 creator A5019892206 @default.
- W2020860419 creator A5026211760 @default.
- W2020860419 creator A5036463296 @default.
- W2020860419 creator A5037981265 @default.
- W2020860419 creator A5039468567 @default.
- W2020860419 creator A5056605939 @default.
- W2020860419 creator A5057671009 @default.
- W2020860419 creator A5086555703 @default.
- W2020860419 date "2000-02-01" @default.
- W2020860419 modified "2023-10-11" @default.
- W2020860419 title "Injury Induces Deficient Interleukin-12 Production, But Interleukin-12 Therapy After Injury Restores Resistance to Infection" @default.
- W2020860419 cites W1480614182 @default.
- W2020860419 cites W1502100938 @default.
- W2020860419 cites W1572332350 @default.
- W2020860419 cites W1754134899 @default.
- W2020860419 cites W1972793829 @default.
- W2020860419 cites W1972922050 @default.
- W2020860419 cites W1982273546 @default.
- W2020860419 cites W1992231572 @default.
- W2020860419 cites W2002008524 @default.
- W2020860419 cites W2014163878 @default.
- W2020860419 cites W2024590208 @default.
- W2020860419 cites W2028612430 @default.
- W2020860419 cites W2047182478 @default.
- W2020860419 cites W2056796152 @default.
- W2020860419 cites W2061986702 @default.
- W2020860419 cites W2069485575 @default.
- W2020860419 cites W2080880272 @default.
- W2020860419 cites W2082649398 @default.
- W2020860419 cites W2411324907 @default.
- W2020860419 cites W2415953033 @default.
- W2020860419 doi "https://doi.org/10.1097/00000658-200002000-00015" @default.
- W2020860419 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1420994" @default.
- W2020860419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10674618" @default.
- W2020860419 hasPublicationYear "2000" @default.
- W2020860419 type Work @default.
- W2020860419 sameAs 2020860419 @default.
- W2020860419 citedByCount "122" @default.
- W2020860419 countsByYear W20208604192012 @default.
- W2020860419 countsByYear W20208604192013 @default.
- W2020860419 countsByYear W20208604192014 @default.
- W2020860419 countsByYear W20208604192015 @default.
- W2020860419 countsByYear W20208604192016 @default.
- W2020860419 countsByYear W20208604192017 @default.
- W2020860419 countsByYear W20208604192019 @default.
- W2020860419 countsByYear W20208604192020 @default.
- W2020860419 countsByYear W20208604192021 @default.
- W2020860419 countsByYear W20208604192022 @default.
- W2020860419 crossrefType "journal-article" @default.
- W2020860419 hasAuthorship W2020860419A5019892206 @default.
- W2020860419 hasAuthorship W2020860419A5026211760 @default.
- W2020860419 hasAuthorship W2020860419A5036463296 @default.
- W2020860419 hasAuthorship W2020860419A5037981265 @default.
- W2020860419 hasAuthorship W2020860419A5039468567 @default.
- W2020860419 hasAuthorship W2020860419A5056605939 @default.
- W2020860419 hasAuthorship W2020860419A5057671009 @default.
- W2020860419 hasAuthorship W2020860419A5086555703 @default.
- W2020860419 hasBestOaLocation W20208604192 @default.
- W2020860419 hasConcept C137061746 @default.
- W2020860419 hasConcept C141071460 @default.
- W2020860419 hasConcept C185592680 @default.
- W2020860419 hasConcept C202751555 @default.
- W2020860419 hasConcept C203014093 @default.
- W2020860419 hasConcept C2777761686 @default.
- W2020860419 hasConcept C2778690821 @default.
- W2020860419 hasConcept C2993242423 @default.
- W2020860419 hasConcept C55493867 @default.
- W2020860419 hasConcept C71924100 @default.
- W2020860419 hasConcept C74172505 @default.
- W2020860419 hasConceptScore W2020860419C137061746 @default.
- W2020860419 hasConceptScore W2020860419C141071460 @default.
- W2020860419 hasConceptScore W2020860419C185592680 @default.
- W2020860419 hasConceptScore W2020860419C202751555 @default.
- W2020860419 hasConceptScore W2020860419C203014093 @default.
- W2020860419 hasConceptScore W2020860419C2777761686 @default.
- W2020860419 hasConceptScore W2020860419C2778690821 @default.
- W2020860419 hasConceptScore W2020860419C2993242423 @default.
- W2020860419 hasConceptScore W2020860419C55493867 @default.
- W2020860419 hasConceptScore W2020860419C71924100 @default.
- W2020860419 hasConceptScore W2020860419C74172505 @default.
- W2020860419 hasIssue "2" @default.
- W2020860419 hasLocation W20208604191 @default.
- W2020860419 hasLocation W20208604192 @default.
- W2020860419 hasLocation W20208604193 @default.
- W2020860419 hasOpenAccess W2020860419 @default.
- W2020860419 hasPrimaryLocation W20208604191 @default.
- W2020860419 hasRelatedWork W2036137330 @default.
- W2020860419 hasRelatedWork W2044056984 @default.
- W2020860419 hasRelatedWork W2073641733 @default.
- W2020860419 hasRelatedWork W2183091990 @default.
- W2020860419 hasRelatedWork W2318823989 @default.
- W2020860419 hasRelatedWork W2351297599 @default.
- W2020860419 hasRelatedWork W2365828934 @default.
- W2020860419 hasRelatedWork W2366209661 @default.
- W2020860419 hasRelatedWork W2376209413 @default.
- W2020860419 hasRelatedWork W2902056154 @default.